Skip to content



Most accessed articles RSS

View all articles


Francesco Marincola, AbbVie Biotherapeutics Corporation, USA 

Journal of Translational Medicine

Translational Medicine Communications is the companion journal to Journal of Translational Medicine.

Aims and scope

Translational Medicine Communications aims to publish open access research, as well as review, methodology and protocol articles that facilitate the communication between basic and clinical science.

The journal covers all areas of translational medicine but also has several special sections:

  • Cancer microenvironment - Edited by Davide Bedognetti
  • Cardiovascular, Metabolic and Lipoprotein Translation- Edited by Nehal N. Mehta
  • Cell, tissue and gene therapy - Edited by David Stroncek
  • Clinical translation - Edited by Lana Kandalaft
  • Combination strategies - Edited by Paolo A. Ascierto
  • Computational modeling and epidemiology- Edited by Michael Liebman and Sabrina Molinaro
  • Disease biomarkers - Edited by Xiangdong Wang
  • Immunobiology and immunotherapy - Edited by Adrian Bot
  • Immunovirology - Edited by Luigi Buonaguro
  • Medical Bioinformatics - Edited by Samir K. Brahmachari
  • Neuroscience - Edited by Luis F. Alguacil
  • Nutrition & metabolism - Edited by Laura Soldati
  • Pain, Critical Care and Anesthesia - Edited by Yasin S. Al Makadma
  • Patient-targeted molecular therapies - Edited by Francesco Chiappelli and Francesco Piva
  • Personalised medicine - Edited by Lotfi Chouchane
  • Translational Imaging - Edited by Ravinder Reddy
  • Translational hematology- Edited by Seah H. Lim

In order to serve the translational science community, Translational Medicine Communications will make an effort to publish any scientifically valid, technically sound articles submitted to the journal.


2016 Journal Metrics

  • Speed
    28 days from submission to first decision
    16 days from acceptance to publication

    244.0 Usage Factor